aspirin has been researched along with Uremia in 46 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
Excerpt | Relevance | Reference |
---|---|---|
"We reported that aspirin (ASA) abnormally prolongs bleeding time (BT) in uremia." | 7.67 | Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition. ( Bonati, M; Gaspari, F; Livio, M; Orisio, S; Remuzzi, G; Viganò, G, 1987) |
"Dialysis did not affect the antiplatelet effects of aspirin and clopidogrel in uremic patients with coronary heart disease." | 3.85 | Effect of Dialysis on Antiplatelet Drug Efficacy in Uremic Patients with Coronary Heart Disease. ( Fu, DL; Gao, YX; Li, XL; Liu, XF; Lu, HK; Peng, WH; Wang, Q; Wang, Y; Yang, P; Zhang, H; Zhao, TT; Zheng, JG, 2017) |
"We reported that aspirin (ASA) abnormally prolongs bleeding time (BT) in uremia." | 3.67 | Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition. ( Bonati, M; Gaspari, F; Livio, M; Orisio, S; Remuzzi, G; Viganò, G, 1987) |
" There was no lysozymuria with severe uraemic heart failure, aspirin and paracetamol poisoning, or severe jaundice, nor in two cases of acute glomerulonephritis." | 3.65 | Lysozymuria and acute disorders of renal function. ( De Silva, KL; Harrison, JF; Parker, RW, 1973) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 38 (82.61) | 18.7374 |
1990's | 3 (6.52) | 18.2507 |
2000's | 2 (4.35) | 29.6817 |
2010's | 3 (6.52) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fu, DL | 1 |
Zhao, TT | 1 |
Peng, WH | 1 |
Yang, P | 1 |
Liu, XF | 1 |
Zhang, H | 1 |
Li, XL | 1 |
Wang, Y | 1 |
Zheng, JG | 1 |
Gao, YX | 1 |
Lu, HK | 1 |
Wang, Q | 1 |
Liu, H | 1 |
Lu, H | 1 |
Basra, SS | 1 |
Tsai, P | 1 |
Lakkis, NM | 1 |
Panichi, V | 1 |
Taccola, D | 1 |
Migliori, M | 1 |
Consani, C | 1 |
Giovannini, L | 1 |
Tetta, C | 1 |
Rodrigue, ME | 1 |
Lacasse-M, S | 1 |
Larivière, R | 1 |
Lebel, M | 1 |
Remuzzi, G | 6 |
Benigni, A | 1 |
Dodesini, P | 1 |
Schieppati, A | 2 |
Livio, M | 2 |
De Gaetano, G | 2 |
Day, SS | 1 |
Smith, WL | 1 |
Pinca, E | 1 |
Patrignani, P | 1 |
Patrono, C | 1 |
Lind, SE | 1 |
Weksler, BB | 1 |
Montgomery, RR | 1 |
Hathaway, WE | 1 |
Malpass, TW | 1 |
Harker, LA | 3 |
Marchesi, D | 1 |
Poletti, E | 1 |
Mecca, G | 1 |
Donati, MB | 1 |
Rossi, EC | 1 |
Viganò, G | 2 |
Caravaca, F | 1 |
López-Minguez, JR | 1 |
Arrobas, M | 1 |
Cubero, J | 1 |
Pizarro, JL | 1 |
Cid, MC | 1 |
Sanchez-Casado, E | 1 |
Miranda, MP | 1 |
Tschugguel, W | 1 |
Blaicher, A | 1 |
Kramer, L | 1 |
Felfernig, M | 1 |
Jüngling, G | 1 |
Kurz, M | 1 |
Gnant, M | 1 |
Zimpfer, M | 1 |
Porter, RJ | 1 |
Layzer, RB | 1 |
Köhler, H | 1 |
Kramer, P | 1 |
Farrell, PC | 1 |
Ward, RA | 1 |
Hone, PW | 1 |
Gaspari, F | 2 |
Orisio, S | 1 |
Bonati, M | 1 |
Jergens, AE | 1 |
Turrentine, MA | 1 |
Kraus, KH | 1 |
Johnson, GS | 1 |
Locatelli, M | 1 |
David, DS | 1 |
Steere, AC | 1 |
Pi-Sunyer, XF | 1 |
Sakai, S | 1 |
Clark, SB | 1 |
Sutor, AH | 1 |
Schindera, F | 1 |
Jacobi, H | 1 |
Künzer, W | 1 |
Murray, RM | 1 |
Timbury, GC | 1 |
Linton, AL | 2 |
MacKenzie, RD | 1 |
Thompson, RJ | 1 |
Gleason, EM | 1 |
Sahud, MA | 2 |
Schöndoft, TH | 1 |
Hey, D | 1 |
Slichter, SJ | 2 |
Rabiner, SF | 1 |
Weiss, HJ | 1 |
Amorosi, EL | 1 |
Andrassy, K | 2 |
Malluche, H | 1 |
Bornefeld, H | 1 |
Comberg, M | 1 |
Ritz, E | 2 |
Jesdinsky, H | 1 |
Möhring, K | 1 |
George, CR | 1 |
Quadracci, LJ | 1 |
Striker, GE | 1 |
Hunt, TK | 1 |
Harrison, JF | 1 |
Parker, RW | 1 |
De Silva, KL | 1 |
Utting, JA | 1 |
Shreeve, DR | 1 |
Dacie, JV | 1 |
Marcus, AJ | 1 |
Hahn, G | 1 |
Schöffner, W | 1 |
Cohen, RJ | 1 |
Lunde, KM | 1 |
Kincaid-Smith, P | 1 |
Horowitz, HI | 1 |
McMillan, JM | 1 |
Lawson, DH | 1 |
Paton, AM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Evaluation of Platelet Aggregation and Adenosine Levels in Patients With Coronary Artery Disease and Chronic Kidney Dysfunction Taking Dual Antiplatelet Therapy With Aspirin and Clopidogrel or Ticagrelor[NCT03039205] | Phase 2 | 90 participants (Actual) | Interventional | 2017-11-07 | Completed | ||
A Double-blind, Randomized, Placebo Controlled Pilot Trial to Evaluate the Safety and Efficacy of Vorapaxar in Maturation of Arteriovenous Fistulae for Hemodialysis Access[NCT02475837] | Phase 2 | 17 participants (Actual) | Interventional | 2015-08-26 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Bleeding events according to GUSTO (criteria for bleeding: Severe, Moderate or Mild) and BARC (bleeding criteria Type 0-5, with 0 being no bleeding and 5 referring to probable or definite fatal bleeding) Criteria (NCT02475837)
Timeframe: up to 238 days
Intervention | Participants (Count of Participants) |
---|---|
Vorapaxar Intervention | 0 |
Placebo Intervention | 1 |
Participants able to use their AV fistula for dialysis within 180 days of surgery were considered to have met the outcome. (NCT02475837)
Timeframe: up to 238 days
Intervention | Participants (Count of Participants) |
---|---|
Vorapaxar Intervention | 2 |
Placebo Intervention | 4 |
Criteria for outcome: AV fistula patency at 150-180 days, with at least 50% increase in vein diameter by ultrasound compared with preoperative vein diameter measurement. (NCT02475837)
Timeframe: 150-238 days
Intervention | Participants (Count of Participants) |
---|---|
Vorapaxar Intervention | 1 |
Placebo Intervention | 5 |
Time to AV fistula functional maturation (defined as successful cannulation of the AV fistula for six hemodialysis sessions within three weeks). (NCT02475837)
Timeframe: up to 238 days
Intervention | Days to functional maturation (Median) |
---|---|
Vorapaxar Intervention | 169 |
Placebo Intervention | 145 |
12 reviews available for aspirin and Uremia
Article | Year |
---|---|
Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease.
Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Chronic Disease; Clinical Trials as Topic; Clopidogrel; | 2011 |
The role of chronic inflammation in cardiovascular mortality of uremic patients.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein; Cardiovascular Diseases; Human | 2003 |
Prolonged bleeding time.
Topics: Aspirin; Bleeding Time; Blood Coagulation Disorders; Cryoglobulins; Evaluation Studies as Topic; Fac | 1984 |
Prostacyclin.
Topics: Adenylyl Cyclases; Adult; Animals; Arteriosclerosis; Aspirin; Blood Platelet Disorders; Blood Platel | 1982 |
Acquired disorders of platelet function.
Topics: Alcoholism; Amyloidosis; Anti-Bacterial Agents; Aspirin; Blood Platelet Disorders; Blood Platelets; | 1980 |
Bleeding disorders in uremia: pathophysiology and treatment.
Topics: Aspirin; Blood Platelet Disorders; Deamino Arginine Vasopressin; Estrogens; Hemorrhage; Humans; Urem | 1989 |
Bleeding in renal failure.
Topics: Anemia; Aspirin; Bleeding Time; Blood Platelets; Blood Transfusion; Cryoprotective Agents; Deamino A | 1988 |
Platelet disorders: a review of disturbances in adhesion, aggregation, and release reaction.
Topics: Adenosine Diphosphate; Afibrinogenemia; Anemia; Aspirin; Blood Platelet Disorders; Connective Tissue | 1972 |
Bleeding in uremia.
Topics: Adenine Nucleotides; Aspirin; Blood Coagulation Disorders; Blood Platelet Disorders; Capillary Fragi | 1972 |
Bleeding disorders due to abnormal platelet function.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Fa | 1973 |
Acute manifestations of platelet dysfunction.
Topics: Acute Disease; Adenosine Diphosphate; Aspirin; Blood Coagulation Factors; Blood Coagulation Tests; B | 1973 |
Platelet function.
Topics: Adenine Nucleotides; Afibrinogenemia; Age Factors; Anemia, Hypochromic; Animals; Aspirin; Blood Cell | 1969 |
4 trials available for aspirin and Uremia
Article | Year |
---|---|
Effect of Aspirin on Reducing Thrombosis of Arteriovenous Fistulae in Uremic Patients Undergoing Hemodialysis.
Topics: Arteriovenous Fistula; Arteriovenous Shunt, Surgical; Aspirin; Catheters, Indwelling; Female; Fibrin | 2019 |
Haemodynamic changes induced by the correction of anaemia by erythropoietin: role of antiplatelet therapy.
Topics: Adult; Aged; Anemia; Aspirin; Dipyridamole; Erythropoietin; Female; Hemodynamics; Humans; Male; Midd | 1995 |
Platelet disorders in uraemia before and after haemodialysis under the influence of low dose aspirin.
Topics: Adult; Aged; Aspirin; Bleeding Time; Blood Platelets; Female; Hematocrit; Hemorrhage; Humans; Male; | 1995 |
Prevention of p.o. clotting of av. cimino fistulae with acetylsalicyl acid. Results of a prospective double blind study.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation; Clinical Trials as Topic; Female; Humans; | 1974 |
30 other studies available for aspirin and Uremia
Article | Year |
---|---|
Effect of Dialysis on Antiplatelet Drug Efficacy in Uremic Patients with Coronary Heart Disease.
Topics: Aged; Aspirin; Clopidogrel; Coronary Disease; Female; Humans; Male; Middle Aged; Platelet Aggregatio | 2017 |
Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta, Thoracic; Aspirin; Blood Pressure; Cyclooxygenase Inhi | 2005 |
Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.
Topics: Adult; Aged; Arachidonic Acids; Aspirin; Blood Platelets; Cyclic AMP; Female; Humans; Male; Middle A | 1983 |
Acute bleeding emergencies.
Topics: Acute Disease; Aspirin; Blood Coagulation Disorders; Blood Platelet Disorders; Blood Vessels; Child; | 1980 |
Aspirin and thrombosis in patients undergoing hemodialysis.
Topics: Aspirin; Humans; Renal Dialysis; Thrombosis; Uremia | 1980 |
Low-dose aspirin and bleeding in uremia.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Humans; Middle Aged; | 1993 |
Plasma albumin concentration and diphenylhydantoin binding in man.
Topics: Adolescent; Adult; Aged; Aspirin; Blood Protein Electrophoresis; Blood-Brain Barrier; Chromatography | 1975 |
[Prophylaxis and therapy of shunt thrombosis in terminal renal insufficiency (author's transl)].
Topics: Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Dextrans; Dipyridamole; Hemorrhagic Disorder | 1977 |
[Analgesic nephropathy].
Topics: Acidosis, Renal Tubular; Analgesics; Aspirin; Autopsy; Caffeine; Creatinine; Drug Interactions; Fema | 1975 |
Uric acid: binding levels of urate ions in normal and uraemic plasma, and in human serum albumin.
Topics: Aspirin; Blood Proteins; Humans; In Vitro Techniques; Protein Binding; Renal Dialysis; Serum Albumin | 1975 |
Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition.
Topics: Acetylation; Adult; Aged; Aspirin; Bleeding Time; Blood Platelets; Cyclooxygenase Inhibitors; Female | 1987 |
Buccal mucosa bleeding times of healthy dogs and of dogs in various pathologic states, including thrombocytopenia, uremia, and von Willebrand's disease.
Topics: Animals; Aspirin; Bleeding Time; Blood Coagulation Tests; Dog Diseases; Dogs; Mouth Mucosa; Thromboc | 1987 |
Determination of aspirin and salicylic acid in uremic patients' plasma using reversed-phase high-performance liquid chromatography.
Topics: Aspirin; Chromatography, High Pressure Liquid; Humans; Salicylates; Salicylic Acid; Uremia | 1987 |
Aspirin-induced hypoglycaemia in a patient on haemodialysis.
Topics: Adult; Aspirin; Chemical and Drug Induced Liver Injury; Humans; Hypoglycemia; Kidney Failure, Chroni | 1971 |
Haemolytic-uraemic syndrome: thrombocyturia after treatment with streptokinase and aspirin.
Topics: Anemia, Hemolytic; Aspirin; Blood Cell Count; Blood Platelets; Child; Hematuria; Hemolytic-Uremic Sy | 1972 |
Analgesic abuse in psychiatric patients.
Topics: Adult; Aged; Anemia; Aspirin; Creatinine; Dyspepsia; Female; Humans; Kidney Diseases; Male; Mental D | 1970 |
Evaluation of a quantitative platelet-collagen adhesiveness test system.
Topics: Aspirin; Chlorpromazine; Collagen; Dialysis; Dose-Response Relationship, Drug; Edetic Acid; Glutaral | 1974 |
Platelet function tests in uraemia and under acetylsalicylic acid administration.
Topics: Aspirin; Blood Platelet Disorders; Female; Humans; Male; Platelet Adhesiveness; Platelet Aggregation | 1974 |
The bleeding time as a screening test for evaluation of platelet function.
Topics: Adult; Aspirin; Blood Cell Count; Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets | 1972 |
A kinetic evaluation of hemostasis in renal disease.
Topics: Aspirin; Blood Coagulation; Complement System Proteins; Diabetic Nephropathies; Dipyridamole; Fibrin | 1974 |
Injury and repair in acute gastroduodenal ulceration.
Topics: Acute Disease; Aspirin; Burns; Cushing Syndrome; Duodenal Ulcer; Gastric Mucosa; Humans; Infections; | 1973 |
Lysozymuria and acute disorders of renal function.
Topics: Acetaminophen; Acute Disease; Aspirin; Electroshock; Glomerulonephritis; Heart Failure; Humans; Hypo | 1973 |
Haemolytic-uraemic syndrome in an adult with pericarditis and pleurisy.
Topics: Adult; Alopecia; Anemia, Hemolytic; Aspirin; Dipyridamole; Female; Hemolytic-Uremic Syndrome; Hepari | 1973 |
[Hemolytic-uremic syndrome and microangiopathic hemolytic anemia].
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic; Aspirin; Dextrans; Dipyridamole; Drug Hypersensitivity; | 1973 |
[Hypercoagulability in patients treated with hemodialysis (diagnosis and therapy)].
Topics: Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Humans; Platelet Adhesiveness; Rena | 1971 |
Aspirin-induced prolongation of the ivy bleeding time. Its diagnostic usefulness.
Topics: Aspirin; Blood Coagulation; Blood Coagulation Disorders; Blood Platelet Disorders; Humans; Time Fact | 1971 |
Plasma protein binding of diphenylhydantoin in man.
Topics: Adult; Aspirin; Bilirubin; Blood Proteins; Carbon Isotopes; Epilepsy; Female; Humans; Hydrogen-Ion C | 1971 |
Analgesic nephropathy. A common form of renal disease in Australia.
Topics: Acetaminophen; Analgesics; Anemia; Animals; Aspirin; Australia; Caffeine; Diagnosis, Differential; D | 1969 |
Uremic toxins and platelet function.
Topics: Adenine Nucleotides; Animals; Aspirin; Blood Platelets; Creatinine; Guanidines; Humans; Mice; Phenol | 1970 |
The occurrence and clinical features of analgesic abuse in Western Scotland.
Topics: Adult; Aged; Anemia, Hemolytic; Anemia, Hypochromic; Anemia, Sideroblastic; Aspirin; Blood Urea Nitr | 1968 |